You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for Patent: 7,262,298

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,262,298 protect, and when does it expire?

Patent 7,262,298 protects LYBALVI and is included in one NDA.

This patent has twenty-nine patent family members in nineteen countries.

Summary for Patent: 7,262,298

Title:	4-hydroxybenzomorphans
Abstract:	4-Hydroxybenzomorphans containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.
Inventor(s):	Wentland; Mark P. (Menands, NY)
Assignee:	Rensselaer Polytechnic Institute (Troy, NY)
Application Number:	11/266,651
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 7,262,298

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Alkermes Inc	LYBALVI	olanzapine; samidorphan l-malate	TABLET;ORAL	213378-001	May 28, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Alkermes Inc	LYBALVI	olanzapine; samidorphan l-malate	TABLET;ORAL	213378-002	May 28, 2021		RX	Yes	No	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Alkermes Inc	LYBALVI	olanzapine; samidorphan l-malate	TABLET;ORAL	213378-003	May 28, 2021		RX	Yes	No	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Alkermes Inc	LYBALVI	olanzapine; samidorphan l-malate	TABLET;ORAL	213378-004	May 28, 2021		RX	Yes	No	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,262,298

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E557006	⤷ Sign Up
Australia	2005304950	⤷ Sign Up
Brazil	PI0517091	⤷ Sign Up
Canada	2587074	⤷ Sign Up
China	101090891	⤷ Sign Up
Cyprus	1112946	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.